Danish drugmaker Novo Nordisk profits jump in diabetes scourge

Danish drugmaker Novo Nordisk profits jump in diabetes scourge

Pharmaceutical company Novo Nordisk, the world's leading insulin provider, on Wednesday reported a six percent jump in net profit in the first quarter, as the global onslaught of diabetes continued to grow.

Danish industry looks on nervously as UK Brexit drama unfolds

Danish industry looks on nervously as UK Brexit drama unfolds